# US 2006/0155234 A1 · Hemostatic dressing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0155234 A1
- Document ID: US20060155234A1
- Status: Published application
- Kind: A1
- Application number: 10/525,415
- Filed: 2003-09-09
- Published: 2006-07-13
- Earliest claimed: 2002-09-10
- Assignees: American National Red Cross
- Inventors: Martin Macphee; Dawson Beall; Stanley Friedman
- Web page: https://patentgrep.com/patent/US20060155234A1

## CPC

- A61F 13/01034: {characterised by a property}
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/00991: {for treating webs, e.g. for moisturising, coating, impregnating or applying powder}
- A61F 13/01029: {made of multiple layers}
- A61K 38/4833: {Thrombin (3.4.21.5)}
- A61L 15/225: {Mixtures of macromolecular compounds}
- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61L 15/64: specially adapted to be resorbable inside the body
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61F 2013/00106: {emergency bandages, e.g. for first aid}
- A61F 2013/00463: {haemostatic}
- A61F 2013/00472: {with chemical means}
- A61F 2013/0054: {for deep wounds}
- A61F 2013/0091: {with disinfecting or anaesthetics means, e.g. anti-mycrobic}
- A61F 2013/00927: {with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors}
- A61L 2400/04: Materials for stopping bleeding
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a hemostatic dressing which comprises a plurality of layers that contain resorbable materials and/or coagulation proteins. In particular, the invention includes dressings in which a layer of thrombin is sandwiched between a first and second layer of fibrinogen and wherein the layer of thrombin is not coextensive with the first and/or second layer of fibrinogen. The hemostatic dressings are useful for the treatment of wounded tissue.

## Claims

### Claim 1

A hemostatic dressing which comprises:
(i) a first fibrinogen layer;
(ii) a thrombin layer adjacent to said first fibrinogen layer; and
(iii) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.

### Claim 2

A hemostatic dressing which comprises:
(i) a resorbable material layer;
(ii) a first fibrinogen layer adjacent to said resorbable material layer;
(iii) a thrombin layer adjacent to said first fibrinogen layer; and
(iv) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.

### Claim 3

A hemostatic dressing which comprises:
(i) a first fibrinogen layer;
(ii) a resorbable material layer adjacent to said first fibrinogen layer;
(iii) a thrombin layer adjacent to said resorbable material layer; and
(iv) a second fibrinogen layer adjacent to said thrombin layer, wherein the thrombin layer is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.

### Claim 4 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.

### Claim 5 (depends on 4)

The hemostatic dressing of claim 4, wherein the thrombin layer is coextensive with 20 to 50% of the first fibrinogen layer.

### Claim 6 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.

### Claim 7 (depends on 6)

The hemostatic dressing of claim 6, wherein the thrombin layer is coextensive with 20 to 50% of the first fibrinogen layer.

### Claim 8 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein the thrombin layer is configured as an array of spots comprising thrombin.

### Claim 9 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein the thrombin layer is configured as a single spot comprising thrombin.

### Claim 10 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein the thrombin layer is configured as a plurality of lines comprising thrombin.

### Claim 11 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, further comprising a backing material.

### Claim 12 (depends on 2)

The hemostatic dressing of claim 2, wherein said resorbable material is selected from the group consisting of glycolic acid polymers, lactic acid polymers and glycolic acid/lactic acid co-polymers.

### Claim 13 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein one or more of said layers comprises a solubilizing agent.

### Claim 14 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein one or more of said layers comprises a filler.

### Claim 15 (depends on 1, 2, 3)

The hemostatic dressing according to any one of claims 1-3, wherein one or more of said layers comprises a binding agent.

### Claim 16 (depends on 1, 2, 3)

A method of treating wounded tissue, which comprises applying to said wounded tissue a hemostatic dressing according to any one of claims 1-3.

### Claim 17 (depends on 16)

The method of claim 16, further comprises hydrating said hemostatic dressing with a liquid that is exogenous to the wounded tissue.

### Claim 18 (depends on 16)

The method of claim 16, further comprising hydrating said hemostatic dressing with a liquid that is endogenous to the wounded tissue.

### Claim 19

A method for preparing a hemostatic dressing, the method comprising:
providing a first layer of fibrinogen;
applying a layer of thrombin to said first layer of fibrinogen; and
applying a second layer of fibrinogen to the layer of thrombin, wherein the layer of thrombin is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.

### Claim 20 (depends on 19)

The method of claim 19, wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.

### Claim 21 (depends on 19)

The method of claim 19, wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.

### Claim 22

A method for preparing a hemostatic dressing, the method comprising:
providing a resorbable or nonresorbable backing layer having attached thereto a first layer of fibrinogen;
applying a layer of thrombin to said first layer of fibrinogen on a side of the fibrinogen layer that is opposite of the side to which the resorbable or nonresorbable backing layer is attached; and
applying a second layer of fibrinogen to the layer of thrombin, wherein the layer of thrombin is noncoextensive with the first fibrinogen layer and/or the second fibrinogen layer.

### Claim 23 (depends on 22)

The method of claim 22, wherein the thrombin layer is coextensive with 5% to 95% of the first fibrinogen layer.

### Claim 24 (depends on 22)

The method of claim 22, wherein the thrombin layer is coextensive with 5% to 95% of the second fibrinogen layer.
